Krystal Biotech, Inc.
KRYS
$256.33
$6.172.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.24% | 107.03% | 7.28% | -21.43% | 67.33% |
| Total Depreciation and Amortization | 48.83% | 0.79% | -24.07% | 47.03% | -13.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 228.42% | -192.14% | 2.22% | 4.23% | -2.96% |
| Change in Net Operating Assets | 134.07% | -5,743.12% | 102.67% | -227.42% | -131.11% |
| Cash from Operations | 95.44% | -24.79% | 70.26% | -41.39% | -10.22% |
| Capital Expenditure | -25.53% | 10.50% | 69.31% | -674.53% | 23.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 615.18% | 70.05% | 82.41% | 40.95% | -149.31% |
| Cash from Investing | 360.45% | 59.28% | 80.78% | 34.63% | -144.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 322.43% | 106.79% | 22.85% | -39.79% | -27.85% |
| Repurchase of Common Stock | -360.00% | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 322.38% | 106.51% | 114.41% | -613.43% | -27.85% |
| Foreign Exchange rate Adjustments | -107.49% | -128.99% | 519.30% | 128.79% | -307.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.44% | -13.95% | 224.83% | -24.03% | -203.27% |